About Us

The end of an era

Shortly after I began as your chair, our CEO for the past 21 years, Tim Padovese, announced that he would be retiring effective February of 2024. While not unexpected, the news is sad for OMIC but exciting for Tim and his fantastic wife, Karen, as this is well deserved. I wanted to highlight for our members Tim’s accomplishments as our CEO.

Read my entire message in the Digest.

Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Six reasons OMIC is the best choice for ophthalmologists in America.

Consistent return of premium.

Publicly-traded insurance companies exist to make profits for shareholders while physician-owned carriers often return profits to their policyholders. Don’t underestimate this benefit; it can add up to tens of thousands of dollars over the course of your career. OMIC has one of the most generous dividend programs for ophthalmologists and has returned more than $90 Million to our members through dividends.